TY  - CHAP
M1  - Book, Section
TI  - Chapter 73. Hematopoietic Stem Cell Transplantation and Graft-versus-Host Disease
A1  - Crawford, Stephen W.
A1  - Folz, Rodney J.
A1  - Sullivan, Keith M.
A2  - Hall, Jesse B.
A2  - Schmidt, Gregory A.
A2  - Wood, Lawrence D.H.
PY  - 2005
T2  - Principles of Critical Care, 3e
AB  - The  principles  of  and  approaches  to  the  critical  care  of  hematopoietic  stem  cell  transplant  recipients  are  similar  to  those  for  other  immunosuppressed  hosts.Specific  complications  tend  to  occur  within  well-defined  time  periods  and  are  influenced  by  the  type  of  stem  cell  transplant.The  primary  distinguishing  features  of  hematopoietic  stem  cell  transplant  recipients  are  the  high  prevalence  of  graft  rejection,  graft-versus-host  reactions,  and  chemoradiotherapy-related  toxicities.Acute  graft-versus-host  disease  represents  a  major  problem  to  allogeneic  hematopoietic  stem  cell  transplantation.Hepatic  veno-occlusive  disease  is  the  most  common  lethal  chemoradiotherapy-related  toxicity  after  hematopoietic  stem  cell  transplantation.When  prophylactic  treatment  is  used,  diffuse  pneumonia  due  to  cytomegalovirus  is  uncommon  after  hematopoietic  stem  cell  transplantation.Idiopathic  pneumonia  syndrome  remains  a  major  cause  of  mortality,  and  no  treatment  has  been  proved  effective.  
SN  - 
PB  - The McGraw-Hill Companies
CY  - New York, NY
Y2  - 2023/03/25
UR  - accesssurgery.mhmedical.com/content.aspx?aid=2294199
ER  -